Medplus Health Services Ltd. IPO

Medplus Health Services Ltd. IPO - SWOT Analysis

Strengths:

There are no publicly traded companies in India with such a wide range of medical and wellness products and services that could give competition to MedPlus Health. Their strategic scale of operations supported by a knowledgeable and well-experienced team of professionals is incomparable.

Weaknesses:

Due to COVID-19, changes may be reflected in the prescription medicine price and commercial terms. This may affect MedPlus Health’s business. There are ongoing legal procedures on the company and all external sources associated with the company are involved in it. In case of any negative outcome from these legal processes, it could have a negative impact on the company.

Opportunities:

As the whole world is facing the pandemic, pharmacy retail outlets are the few stores that found sales opportunities. This is reflected in MedPlus Health’s business too. Their regional trends and the market dynamics knowledge, along with their ability to facilitate store development with well-equipped warehouses and distribution centres, can contribute to expanding their retail network in the coming years.

Threats:

Anything affecting the Indian pharmaceutical sector can affect MedPlus Health’s business. They depend on the use of prescription medications, and their brand name or generic drugs. Any negative impact on them could reflect in their sales and margins which may lose them money. They have a history of engagement in related party transactions and this could repeat in the future.